After nearly two decades serving as President and Chief Executive Officer of Vanderbilt Health and Dean of Vanderbilt University School of Medicine, Jeff Balser, MD, PhD, will retire from both leadership roles on Dec. 31. A national search for his successor, who will hold both leadership roles, will be led by the Vanderbilt Health Board of Directors.
Balser’s announcement culminates a career-long journey that began at Vanderbilt in the mid-1980s as a medical student and doctoral dual degree candidate. With degrees in hand in 1990, he departed for a residency in anesthesiology and fellowships in cardiac anesthesiology and critical care medicine at Johns Hopkins Hospital, where he joined the faculty in 1995. At Johns Hopkins, he was a cardiac anesthesiologist and surgical intensivist who led a National Institutes of Health-funded research program aimed at genomic causes of cardiac rhythm disorders.
In 1998, Balser was recruited back to Vanderbilt as a clinician, investigator, and as the first associate dean for Physician-Scientist Development, beginning a series of successively responsible leadership roles. In 2001, he was named the James Tayloe Gwathmey Professor and chair of the Department of Anesthesiology. In 2004 (during an era when Vanderbilt Health used academic leadership titles), he became the associate vice chancellor for Research, leading the Medical Center’s research growth agenda.
In 2008, Balser became the 12th Dean of Vanderbilt University School of Medicine (VUSM) since the school’s founding in 1875. In addition to his responsibilities as dean, he also served as associate vice chancellor for Health Affairs, with continued oversight for Medical Center research.
In 2009, at age 47, Balser was appointed to the Medical Center’s top role, vice chancellor for Health Affairs, making him the youngest person to ever hold this position. Setting another institutional precedent, for the past 17 years he has continued to serve in both roles, as the Medical Center’s chief executive and medical school dean.
As Balser took the helm of Vanderbilt Health, the U.S. economy was in one of the greatest financial crises since the Great Depression, caused by the collapse of the home mortgage industry. At that point, the Medical Center had $2.3 billion in annual net revenues, 16,000 employees and 2,100 full-time faculty, and its cash reserves were depleted.
Relentlessly optimistic despite many challenges facing the Medical Center, the nation’s health care industry and the overall economy, Balser said to a gathering of Medical Center leaders at the time, “We will work hard. We will accomplish a great deal, and we will do it as a team. I need the support of everyone here.”
By every measure, the past 17 years have been transformative for Vanderbilt Health and VUSM. Today, Balser leads an organization composed of an internationally recognized eight-hospital health system with more than 2,000 beds and 200 ambulatory locations across five states, caring for more than 4 million patients each year. Vanderbilt Health’s workforce now exceeds 45,000, including 5,000 employed clinicians and scientists.
“The Medical Center and its many unique assets are a treasured resource for people across Tennessee and throughout the region. Through his vision and initiative, Dr. Balser has led an era of remarkable growth in facilities, programs and services that will have a lasting impact on the lives of generations of patients and their families,” said Edie Carell Johnson, JD, chair of the Vanderbilt Health Board of Directors. “On behalf of the board, I want to express my gratitude to Jeff for his decades of service in support of the Medical Center’s mission.”
From the outset, Balser understood the value of frequent communication and has by now spoken before thousands of meetings, assemblies and forums, as well as having authored hundreds of first-person “Rounds” messages in an era before his now frequent videos for all employees.
The Medical Center’s scientific discoveries, training programs and clinical advancements are responsible for numerous institutional strengths, such as the Vanderbilt Transplant Center becoming the world’s leading center for heart transplants and solid organ transplants in aggregate; being home to the Southeast’s highest-ranked children’s hospital and the nation’s fifth largest neonatal intensive care unit; the Mid-South’s largest National Cancer Institute-designated Comprehensive Cancer Center; and the principal Level 1 trauma center in Tennessee and one of the busiest in the nation. Vanderbilt Health is also home to the region’s largest health professions training center with more than 1,300 physicians training in 200 specialties.
Pivotal to Vanderbilt Health’s explosive growth was the effort Balser led with Vanderbilt University leadership during 2015-2016 to legally and financially separate Vanderbilt Health from the university, allowing the Medical Center to become its own nonprofit entity while still maintaining close ties between the two institutions that continue to fuel academic excellence and scientific discoveries.
In this independent structure, Vanderbilt Health’s campuses have expanded from two to six as net revenues have grown more than threefold to $9 billion annually, while days of cash on hand, a measure of organizational financial health, have increased from 50 to more than 110, with total cash on hand and investments now exceeding $3 billion. Over two decades, Vanderbilt Health’s discovery portfolio has grown to nearly $1 billion in research grants and contracts. Total National Institutes of Health (NIH) funding over the last two decades has grown significantly, from 24th at the turn of the century to now repeatedly ranking in the nation’s top 10, landing seventh at the end of 2025 despite federal slowdowns in grant awards.
As dean of VUSM, Balser oversees the school’s degree-granting programs and faculty affairs and has by now graduated thousands of physicians, physician-scientists and other health care professionals. In 2012, VUSM unveiled a new four-year model for medical education affectionately called Curriculum 2.0. The curriculum, carefully developed over a yearslong period, was designed to address the ever-advancing accumulation of knowledge in health care. Curriculum 2.0 transformed medical education at Vanderbilt and impacted medical curricula nationwide by focusing on deeply integrated coursework requiring flexibility and teamwork on the part of faculty and students.
In 2007, the Medical Center launched BioVU, which is now the nation’s largest single-site DNA repository linked to de-identified health record information. BioVU has proven such an asset that Vanderbilt Health developed a wholly owned company called Nashville Biosciences for engaging industry, which was the catalyst for an alliance of 10 major pharmaceutical companies, the Alliance for Genomic Discovery (AGD), investing over $100 million to whole genome sequence BioVU. AGD companies and investigators across the Medical Center and university are now using BioVU’s data to speed up drug discovery and development.
Vanderbilt Health’s steady investment in biomedical informatics and personalized medicine has allowed the institution to set the pace nationally in this area, leading to the 2016 announcement of a $71.6 million NIH grant, the single largest award in Vanderbilt’s history, for the Medical Center to become home to the Data and Research Center for NIH’s All of Us million-plus person precision medicine program, a responsibility it continues to hold today.
Along the way, Balser has been the proponent of a workplace culture that, whenever possible, seeks to develop and promote talented employees from within the organization. Many of his direct reports have gone on to top positions in academia, including becoming medical school deans, a university president and director of the National Cancer Institute.
Recent examples of Balser’s impact on the growth of Vanderbilt Health include the addition of Jim Ayers Tower, the largest, single hospital construction expansion in Vanderbilt University Hospital’s history, completion of a four-floor expansion to Monroe Carell Jr. Children’s Hospital at Vanderbilt, and the addition of 270-bed Vanderbilt Clarksville Hospital to Vanderbilt Health. He will be retiring with plans in place, including final government approval, for the construction of a new freestanding hospital in Murfreesboro, to be called Vanderbilt Health Rutherford County.